Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Clinical trial register
Trackers› Clinical trials› China
Clinical trial register · China

Clinical Trials in China

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19282 matching records held by the registry are in this view. Synced 16 Nov 2026, 03:17 UTC
19282
Studies in scope
all four open statuses
11840
Recruiting now
open to new participants
2032
Lead sponsors
across recruiting studies
Top sites
Chengdu 160 Chongqing 5 Sichuan 4 Beijing 4 Xiamen 3
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Trials in this register

166 of 19282 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
West China Hospital
Observational
380
Chengdu
2027-01-01
Not yet open
West China Hospital
Not applicable
60
Beijing, Chengdu, Chongqing, Fuzhou, Guangzhou, Nanjing, Shanghai
2026-12-01
Recruiting
West China Hospital
Phase 2
128
Chengdu
2026-11-05
Not yet open
West China Hospital
Not applicable
200
Chengdu
2026-10-01
Recruiting
West China Hospital
Phase 2
140
Chengdu
2026-09-28
Recruiting
Vericiguat for the Inhibition of Calcific Aortic Valve Stenosis Progression
NCT07715279Calcific Aortic Valve Disease, AORTIC VALVE DISEASES, Aortic Valve Stenosis
West China Hospital
Phase 2
238
Chengdu
2026-09-24
Recruiting
West China Hospital
Phase 1/2
45
Chengdu
2026-09-21
Not yet open
PSMA PET/CT-Guided SBRT Plus Darolutamide in mHSPC
NCT07649421Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
West China Hospital
Phase 2
254
Chengdu
2026-09-15
Recruiting
West China Hospital
Phase 1
15
Chengdu
2026-09-10
Recruiting
Wireless Wearable Home Prehabilitation for Older Adults With NSCLC
NCT07809763Non-Small Cell Lung Cancer (NSCLC), Rehabilitation, Thoracic Surgery, Prehabilitation
West China Hospital
Not applicable
196
Chengdu
2026-09-10
Recruiting
West China Hospital
Not applicable
116
Chengdu
2026-09-10
Recruiting
West China Hospital
Phase 2
40
Chengdu, Luzhou, Meishan, Nanchong, Suining, Zigong
2026-09-10
Not yet open
JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure
NCT07175389Refractory Pancreatic Ductal Adenocarcinoma, Refractory Pancreatic Adenocarcinoma
West China Hospital
Phase 1/2
10
Chengdu
2026-09-01
Recruiting
Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME)
NCT07718126Metabolic Dysfunction-Associated Steatohepatitis, Hepatic Steatosis, Living Liver Donors
West China Hospital
Phase 4
60
Hefei, Beijing, Chongqing, Chengdu
2026-09-01
Recruiting
Zusanli (ST36) Electroacupuncture Treatment for Neoadjuvant Immunotherapy in Non-Small Cell Lung Cancer
NCT07076836Lung Cancer (NSCLC), Immune Checkpoint Blockade, Electroacupuncture
West China Hospital
Not applicable
82
Chengdu
2026-08-31
Not yet open
Rehabilitation With Wearable Monitors for Post-Lung Cancer Surgery
NCT07733492Non-Small Cell Lung Cancer (NSCLC), Rehabilitation, Thoracic Surgery
West China Hospital
Not applicable
126
Chengdu
2026-08-31
Not yet open
Digital Rehabilitation With Wearable Monitors for Sequential Lung Cancer Resection
NCT07797075Non-Small Cell Lung Cancer (NSCLC), Rehabilitation, Thoracic Surgery
West China Hospital
Not applicable
222
Chengdu
2026-08-31
Recruiting
Phase II Study of Subretinal JWK001 for Neovascular Age-Related Macular Degeneration
NCT07776522Neovascular Age-Related Macular Degeneration (nAMD) Wet AMD
West China Hospital
Phase 2
50
Beijing, Jilin City, Chongqing, Shantou, Zhejiang, Harbin, Zhengzhou, Wuhan
2026-08-31
Recruiting
Online Sharing for Head & Neck Cancer Support
NCT07766226Head and Neck Squamous Cell Carcinoma
West China Hospital
Not applicable
120
Chengdu
2026-08-28
Recruiting
YMN-136 Vaccine for Patients With Advanced Hepatobiliary and Pancreatic Malignancies
NCT07763301Liver Cancer, Pancreatic Cancer, Biliary Tract Cancer (BTC)
West China Hospital
Phase 1
9
Chengdu
2026-08-01
Not yet open
Underdilated VCX-TIPS Versus EVL Plus NSBB for Secondary Prophylaxis of Variceal Bleeding in Cirrhosis
NCT07587671Liver Cirrhosis, Portal Hypertension, Gastroesophageal Varices Bleeding, Esophageal Varices
West China Hospital
Not applicable
240
Chengdu, Chongqing, Xiamen
2026-08-01
Not yet open
West China Hospital
Phase 2
49
Chengdu
2026-08-01
Not yet open
West China Hospital
Phase 2
25
Chengdu
2026-08-01
Not yet open
West China Hospital
Phase 2
66
Chengdu
2026-08
Not yet open
YMN-A02 for Advanced pMMR Colorectal Cancer With Liver Metastases
NCT07610707Colorectal Cancer With Liver Metastatic
West China Hospital
Phase 1
10
Chengdu
2026-07-30
Not yet open
YMN-A02 for Advanced Primary Hepatocellular Carcinoma.
NCT07580261Hepatocellular Carcinoma
West China Hospital
Phase 1
10
Chengdu
2026-07-30
Recruiting
West China Hospital
Phase 1
18
Chengdu
2026-07-13
Not yet open
West China Hospital
Phase 4
110
Chengdu
2026-07-01
Recruiting
West China Hospital
Phase 2
9
Chengdu
2026-06-29
Not yet open
West China Hospital
Observational
150
Chengdu
2026-06-20
Recruiting
Clinical Study of CFH Protein Via Ice Microneedles for Radiation-Induced Skin Fibrosis
NCT07567235Radiation-Induced Skin Fibrosis, Head and Neck Squamous Cell Carcinoma
West China Hospital
Phase 1
9
Chengdu
2026-06-15
Recruiting
West China Hospital
Phase 1
9
Chengdu
2026-06-11
Recruiting
Akkermansia Muciniphila (AKK) for Radiation-Induced Skin Injury
NCT07635277Radiation-Induced Skin Injury
West China Hospital
Phase 1
40
Chengdu
2026-06-07
Recruiting
West China Hospital
Phase 1
54
Chengdu
2026-06-05
Active, closed
Anlotinib+Cadonilimab+PULSAR in Advanced Biliary Tract Cancer
NCT07635290Previously Treated, Advanced, Biliary Tract Cancers
West China Hospital
Phase 2
26
Chengdu
2026-06-03
Not yet open
West China Hospital
Observational
70
Chengdu
2026-06-01
Recruiting
West China Hospital
Phase 1/2
20
Chengdu
2026-06
Recruiting
Intranasal WSK-IM05 Vaccine Plus Tislelizumab as Neoadjuvant Therapy for HPV+ OPSCC
NCT07565740HPV-positive Oropharyngeal Squamous Cell Carcinoma
West China Hospital
Phase 1
9
Chengdu
2026-05-15
Recruiting
West China Hospital
Phase 2
30
Chengdu
2026-05-11
Recruiting
West China Hospital
Phase 1
9
Chengdu
2026-05-10
Recruiting
West China Hospital
Phase 1
9
Chengdu
2026-05-06
Not yet open
West China Hospital
Not applicable
1,508
Chengdu
2026-05-01
Not yet open
West China Hospital
Early Phase 1
10
Chengdu
2026-05-01
Not yet open
West China Hospital
Phase 3
412
Chengdu
2026-05-01
Not yet open
A Study of Ta-NPs Plus Radiotherapy for Locally Recurrent Retroperitoneal Sarcoma
NCT07578506Locally Recurrent Retroperitoneal Soft Tissue Sarcoma
West China Hospital
Phase 1
9
Chengdu
2026-05-01
Recruiting
IMP3-saRNA Vaccine in Advanced NSCLC
NCT07561723Non-Small Cell Lung Cancer
West China Hospital
Phase 1
9
Chengdu
2026-04-30
Recruiting
West China Hospital
Phase 1
9
Chengdu
2026-04-28
Not yet open
West China Hospital
Phase 1
9
Chengdu
2026-04-28
Recruiting
West China Hospital
Phase 1
6
Chengdu
2026-04-28
Recruiting
West China Hospital
Phase 1
6
Chengdu
2026-04-23
Recruiting
Controlled Cold Exposure Combined With PD-1/PD-L1 Immunotherapy in Solid Tumors (NIVALIS)
NCT07538479Solid Tumors, Solid Malignancies, Cold Exposure, Immunotherapy
West China Hospital
Phase 1
24
Chengdu
2026-04-20
Recruiting
MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients
NCT07509333Lung Neoplasms, Carcinoma, Non-Small-Cell Lung, Small Cell Lung Carcinoma
West China Hospital
Not applicable
2,000
Chengdu
2026-04-05
Recruiting
West China Hospital
Phase 1
9
Chengdu
2026-04-01
Recruiting
NALIRIFOX+Adebrelimab+PULSAR for Advanced Pancreatic Cancer
NCT07595172Pancreatic Ductal Adenocarcinoma (PDAC), Locally Advanced and Metastatic Pancreatic Cancer
West China Hospital
Phase 1/2
55
Chengdu
2026-04
Recruiting
West China Hospital
Phase 1
9
Chengdu
2026-03-27
Recruiting
West China Hospital
Phase 2
118
Chengdu
2026-03-16
Recruiting
West China Hospital
Phase 3
170
Chengdu
2026-03-15
Active, closed
West China Hospital
Observational
500
Chengdu
2026-03-06
Recruiting
H101 Plus TACE for r/m HNSCC
NCT07398664Head and Neck Squamous Cell Carcinoma, Oncolytic Virus, TACE
DrugH101
West China Hospital
Phase 2
20
Chengdu
2026-03-02
Recruiting
West China Hospital
Observational
2,000
Hefei, Chongqing, Guangzhou, Harbin, Wuhan, Nanjing, Tianjin
2026-03-01
Recruiting
Surgery vs. Watch-and-Wait Strategy in Partial & Complete Responders for Hepatocellular Carcinoma
NCT07410715HCC - Hepatocellular Carcinoma, Watch & Wait, Surgery
West China Hospital
Observational
100
Chengdu
2026-03-01
Recruiting
West China Hospital
Phase 2/3
60
Chengdu
2026-03-01
Recruiting
West China Hospital
Not applicable
20
Chengdu
2026-03-01
Recruiting
West China Hospital
Observational
200
Beijing, Xuzhou, Chengdu
2026-03-01
By invitation
West China Hospital
Observational
300
Chengdu
2026-03-01
Not yet open
West China Hospital
Not applicable
198
Chengdu
2026-02-09
Recruiting
West China Hospital
Phase 1/2
33
Chengdu
2026-02
Not yet open
Spirulina Derivative for Radiation Esophagitis
NCT07324018Radiation-induced Esophagitis
West China Hospital
Phase 2
70
Chengdu
2026-01-12
Active, closed
Gamified Neurology Grand Rounds
NCT07419984Education, Medical, Grand Rounds
West China Hospital
Not applicable
240
Chengdu
2026-01-01
Recruiting
The Construction and Clinical Application of an Integrated Perioperative Management System for Lung Cancer Based on Wearable Devices and Intelligent Platforms
NCT07310056Non-Small Cell Lung Cancer (NSCLC), Rehabilitation, Thoracic Surgery, Perioperative Management
West China Hospital
Not applicable
126
Chengdu
2026-01-01
Not yet open
West China Hospital
Observational
3,200
Chengdu
2026-01-01
Recruiting
West China Hospital
Observational
20
Chengdu
2026-01-01
Recruiting
West China Hospital
Early Phase 1
30
Chengdu
2026-01-01
Not yet open
UDCA to Prevent Post-TIPS Hepatic Encephalopathy
NCT07273734Hepatic Encephalopathy (HE), TIPS
West China Hospital
Not applicable
270
Chengdu
2026-01-01
Not yet open
Cellular-Level Fluorescence Imaging for Intraoperative Margin Assessment in Breast Cancer
NCT07311317Breast Cancer Early Stage Breast Cancer (Stage 1-3)
West China Hospital
Observational
165
Chengdu
2026-01
Recruiting
West China Hospital
Observational
250
Chengdu
2025-12-29
Recruiting
West China Hospital
Early Phase 1
18
Chengdu
2025-12-22
Recruiting
West China Hospital
Phase 1/2
9
Chengdu
2025-12-16
Active, closed
West China Hospital
Phase 1
20
Chengdu
2025-12-01
Not yet open
West China Hospital
Phase 3
528
Chengdu
2025-12-01
Recruiting
West China Hospital
Phase 4
232
Xi’an, Chengdu
2025-11-19
Recruiting
Hypofractionated Radiotherapy Plus Immunochemotherapy for Neoadjuvant Treatment of Gastroesophageal Junction Adenocarcinoma
NCT07182565Gastroesophageal Junction Adenocarcinoma, Hypofractionated Radiotherapy
DrugTS-1
West China Hospital
Phase 1/2
84
Xiamen, Chengdu
2025-11-18
Recruiting
West China Hospital
Phase 1
9
Chengdu
2025-10-23
Recruiting
Non-pharmacological Auditory and Somatosensory Stimulation in Anesthetic Emergence
NCT07339618General Anesthetic, Electroencephalographic
West China Hospital
Not applicable
205
Chengdu
2025-10-11
Not yet open
West China Hospital
Observational
700
Chengdu
2025-10-05
Recruiting
Hypofractionated Radiotherapy Combined With Immunochemotherapy for Conversion Treatment of Gastroesophageal Junction Adenocarcinoma
NCT07072351Gastroesophageal Junction Adenocarcinoma, Hypofractionated Radiotherapy, Immunotherapy, Chemotherapy
West China Hospital
Phase 1/2
88
Xiamen, Chengdu
2025-09-15
Recruiting
West China Hospital
Phase 2
120
Chengdu
2025-09-13
Recruiting
West China Hospital
Phase 1/2
45
Chengdu
2025-09-10
Recruiting
A Study of GV20-0251 in Advanced or Refractory Solid Tumors
NCT07106827HCC - Hepatocellular Carcinoma, Cholangiocarcinoma, Melanoma, NSCLC (Non-small Cell Lung Cancer)
West China Hospital
Phase 1
10
Chengdu
2025-09-04
Recruiting
West China Hospital
Phase 1
15
Chengdu
2025-08-01
Recruiting
West China Hospital
Phase 1
15
Chengdu
2025-07-31
Not yet open
West China Hospital
Not applicable
242
Chengdu
2025-07-30
Recruiting
West China Hospital
Not applicable
5
Chengdu
2025-07-25
Recruiting
West China Hospital
Not applicable
40
Chengdu
2025-07-23
Not yet open
West China Hospital
Not applicable
20
Chengdu
2025-07-20
Recruiting
West China Hospital
Not applicable
30
Chengdu
2025-07-15
Active, closed
West China Hospital
Phase 1/2
20
Chengdu
2025-07-07
Active, closed
West China Hospital
Phase 2
70
Chengdu
2025-06-27
Recruiting
West China Hospital
Observational
1,200
Chengdu
2025-06-16
Active, closed
West China Hospital
Phase 1/2
29
Chengdu
2025-06-10
Recruiting
West China Hospital
Phase 1
12
Chengdu
2025-05-09
Not yet open
West China Hospital
Not applicable
600
Chengdu
2025-05-01
Recruiting
West China Hospital
Phase 2
23
Chengdu
2025-04-16
Recruiting
Prognostic Impact of Adjuvant Therapy in Primary Hepatic Sarcomatoid Carcinoma
NCT06950814Sarcomatoid Carcinoma, Liver Cancer, Adjuvant Therapy
West China Hospital
Observational
50
Chengdu
2025-04-05
Recruiting
Textbook Outcomes of Right Hemihepatectomy in Patients With Hepatocellular Carcinoma
NCT06950827Hepatocellular Carcinoma, Hepatectomy, Laparoscopic Hepatectomy
West China Hospital
Observational
400
Chengdu
2025-04-05
Recruiting
West China Hospital
Observational
459
Chengdu
2025-03-29
Recruiting
West China Hospital
Phase 2
28
Chengdu
2025-03-15
Active, closed
Akkermansia Probiotics Plus Anti-PD-1 Monoclonal Antibody in MSS/pMMR Advanced Colorectal Cancer
NCT06865521Colo-rectal Cancer, PD-1 Inhibitor, Akkermansia Muciniphila
West China Hospital
Not applicable
22
Chengdu
2025-02-21
Active, closed
West China Hospital
Phase 1/2
20
Chengdu
2025-02-10
Not yet open
Fascia Iliaca Compartment Block and Tramadol for Analgesia in Hip Fracture
NCT06728033Hip Fractures, Ultrasound-guided Nerve Block, Perioperative Analgesia
West China Hospital
Not applicable
240
Chengdu
2025-01-01
Not yet open
Erector Spinae Plane Block v.s Patient Controlled Analgesia in Correction Surgery for Idiopathic Scoliosis
NCT06728046Idiopathic Scoliosis, Erector Spinae Plane Block, Patient Controlled Analgesia
West China Hospital
Not applicable
40
Chengdu
2025-01-01
Recruiting
West China Hospital
Phase 2/3
32
Chengdu
2025-01-01
Not yet open
West China Hospital
Phase 2
50
Chengdu
2025-01-01
Recruiting
West China Hospital
Phase 1/2
57
Chengdu
2024-12-31
Not yet open
West China Hospital
Phase 2
20
Chengdu
2024-12-01
Recruiting
West China Hospital
Phase 2/3
150
Chengdu
2024-11-30
Recruiting
Personalized Long-course Radiotherapy Plus Chemotherapy With or Without Immunotherapy for LARC: PALACE Study
NCT07020247Locally Advanced Rectal Cancer (LARC), Immunotherapy, Radiotherapy, Total Neoadjuvant Therapy
West China Hospital
Phase 3
184
Chengdu
2024-11-19
Recruiting
West China Hospital
Observational
10,000
Chengdu
2024-11-11
Recruiting
West China Hospital
Phase 3
100
Chengdu
2024-11-10
Not yet open
West China Hospital
Not applicable
150
Nanchang, Chengdu
2024-11-10
Recruiting
SBRT Combined With PD-1 Inhibitor and Chemotherapy in Early-stage TNBC
NCT06627712TNBC - Triple-Negative Breast Cancer
DrugSBRT
West China Hospital
Phase 3
318
Sichuan
2024-11-01
Recruiting
West China Hospital
Phase 3
186
Chengdu
2024-11-01
Active, closed
West China Hospital
Phase 1
6
Chengdu
2024-10-27
Active, closed
West China Hospital
Phase 2
58
Chengdu
2024-10-10
Recruiting
West China Hospital
Phase 2
36
Chengdu
2024-10-01
Not yet open
Clinical Study of Therapeutic Immunological Agent for EBV Lymphoproliferative Diseases
NCT06666153CAEBV (Chronic Active Epstein-Barr Virus Infection) Syndrome, PTLDs
West China Hospital
Phase 1
27
Chengdu
2024-10
Recruiting
AI App for Management of Atopic Dermatitis
NCT06362629Atopic Dermatitis, Artificial Intelligence
West China Hospital
Not applicable
232
Chengdu
2024-09-01
Recruiting
West China Hospital
Phase 2
51
Chengdu
2024-08-30
Recruiting
A Study of Online Follow-up in Patients With Papillary Thyroid Cancer
NCT06800482Thyroid, Papillary Thyroid Cancer
West China Hospital
Not applicable
388
Chengdu
2024-08-07
Recruiting
West China Hospital
Not applicable
16
Chengdu, Zigong
2024-08-03
Recruiting
West China Hospital
Not applicable
12
Chengdu
2024-08-03
Recruiting
West China Hospital
Phase 1
6
Chengdu
2024-07-22
Recruiting
West China Hospital
Phase 2
86
Sichuan
2024-06-30
Active, closed
West China Hospital
Observational
850,000
Chengdu
2024-06-01
Recruiting
Individualized ANH for Non-cardiac Surgery
NCT06399536Transfusion Related Complication, Hemodilution
West China Hospital
Not applicable
40
Chengdu
2024-06-01
Recruiting
West China Hospital
Not applicable
524
Chengdu
2024-05-06
Recruiting
West China Hospital
Phase 2
60
Guiyang, Chengde, Chengdu, Kunming
2024-03-25
Not yet open
Preemptive TIPS for Variceal Bleeding in Cirrhotic Patients With Occlusive Portal Vein Thrombosis
NCT06122753Portal Hypertension, Portal Vein Thrombosis, Esophageal Varix Bleeding, Portosystemic Shunt
West China Hospital
Not applicable
120
Chengdu
2024-01
Recruiting
West China Hospital
Not applicable
100
Chengdu
2023-12-10
Recruiting
West China Hospital
Phase 2
17
Chengdu
2023-11-30
Active, closed
West China Hospital
Phase 1/2
9
Chengdu
2023-11-20
Recruiting
West China Hospital
Early Phase 1
12
Chengdu
2023-11-17
Recruiting
Assessment System of Sarcopenia in Lung Cancer Patients
NCT06327594Sarcopenia, Lung Cancer, Ultrasound
West China Hospital
Observational
1,500
Chengdu
2023-11-01
Recruiting
Physiological Studies in the Prone Position in Patients With ARDS
NCT06586736Acute Respiratory Distress Syndrome, Mechanical Ventilation, Prone Positioning
West China Hospital
Observational
100
Chengdu
2023-09-01
Recruiting
West China Hospital
Not applicable
276
Sichuan
2023-06-05
By invitation
West China Hospital
Not applicable
100
Chengdu
2023-06-01
Recruiting
West China Hospital
Not applicable
304
Chengdu
2023-05-05
Recruiting
West China Hospital
Phase 2
200
Chengdu
2023-03-08
Active, closed
West China Hospital
Phase 1
6
Chengdu
2023-02-08
Active, closed
West China Hospital
Phase 1
19
Chengdu
2023-02-08
Recruiting
West China Hospital
Observational
1,300
Sichuan
2022-05-01
Active, closed
West China Hospital
Phase 3
554
Wuxi, Chengdu, Kunming
2021-08-26
Recruiting
West China Hospital
Phase 2
75
Chengdu
2021-06-01
Recruiting
West China Hospital
Observational
500
Chengdu
2021-01-01
Recruiting
West China Hospital
Observational
1,500
Chengdu
2020-10-01
Recruiting
West China Hospital
Observational
300
Chengdu
2019-01-01
Recruiting
West China Hospital
Phase 2/3
250
Chengdu
2018-04-10
Rows per page Showing 1–166 of 166
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 16 November 2026. https://priyalifescience.com/clinical-trials-china

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,282 studies in total at the last sync on 16 Nov 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 166 of those studies that match the filters currently applied.

How many clinical trials are recruiting in China?

109 of the 166 studies on this page are recruiting new participants as of the 16 Nov 2026, 03:17 UTC sync. A further 38 have not yet opened recruitment, 17 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase, 166 studies
PhaseStudiesRecruitingShare
Not applicable382022.9%
Phase 1352521.1%
Phase 2322219.3%
Observational271816.3%
Phase 1/215109%
Phase 3854.8%
Early Phase 1432.4%
Phase 2/3442.4%
Phase 4321.8%

Most active sponsors

Lead sponsors with the most studies
Lead sponsorStudiesRecruiting
West China Hospital166109

This register, in your inbox every Friday

One email a week with how many trials are recruiting in Ireland, new EMA and FDA approvals and medicine shortages, built from the same public registers as this page.

Free. Unsubscribe from any email with one click. See our privacy policy.

→

Browse trials by condition

Liver Cancer (6) Immunotherapy (5) Head and Neck Squamous Cell Carcinoma (5) Non-Small Cell Lung Cancer (NSCLC) (4) Rehabilitation (4) Thoracic Surgery (4) Colorectal Cancer (4) mRNA Vaccine (3) Rectal Cancer (3) Radiation Dermatitis (3) Hepatocellular Carcinoma (3) Radiation-induced Oral Mucositis (2) Radiation-induced Dermatitis (2) Malignant Tumor (2) HCC - Hepatocellular Carcinoma (2)
→

Browse trials by site location

Chengdu (160) Chongqing (5) Sichuan (4) Beijing (4) Xiamen (3) Hefei (2) Guangzhou (2) Harbin (2) Wuhan (2) Nanjing (2) Kunming (2) Tianjin (1) Wuxi (1) Nanchang (1)
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.